Mesenchymal stem cells with downregulated Hippo signaling attenuate lung injury in mice with lipopolysaccharide-induced acute respiratory distress syndrome

International Journal of Molecular Medicine

Volumn 43, Issue 3, 2019, Pages 1241-1252

  Li, Lang ^a   Dong, Liang ^a   Zhang, Jiangqian ^a   Gao, Fei ^a   Hui, Jiaojie ^a   Yan, Jie ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

acute respiratory distress syndrome; alveolar type II epithelial cell; Hippo signaling; large tumor suppressor kinase 1; mesenchymal stem cell

Indexed keywords

ALBUMIN; CELL PROTEIN; HIPPO PROTEIN; LIPOPOLYSACCHARIDE; PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; HIPPO PROTEIN, MOUSE; LATS1 PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE;

ADULT RESPIRATORY DISTRESS SYNDROME; ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BRONCHOALVEOLAR LAVAGE FLUID; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE KNOCKDOWN; IN VIVO STUDY; LUNG ALVEOLUS CELL TYPE 2; LUNG FIBROSIS; LUNG INJURY; LUNG PARENCHYMA; LUNG WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; ACUTE LUNG INJURY; ANIMAL; CELL MEMBRANE PERMEABILITY; CYTOLOGY; DISEASE MODEL; FIBROSIS; GENE KNOCKOUT; GENE VECTOR; GENETICS; LENTIVIRUS; MALE; MESENCHYMAL STEM CELL; METABOLISM; PATHOLOGY; RESPIRATORY MUCOSA;

ACUTE LUNG INJURY; ANIMALS; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; DISEASE MODELS, ANIMAL; FIBROSIS; GENE KNOCKOUT TECHNIQUES; GENETIC VECTORS; LENTIVIRUS; LIPOPOLYSACCHARIDES; MALE; MESENCHYMAL STEM CELLS; MICE; PROTEIN-SERINE-THREONINE KINASES; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION;

EID: 85061060963     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2018.4047     Document Type: Article

References (51)

1. Thompson BT, Chambers RC and Liu KD: Acute respiratory distress syndrome. N Engl J Med 377: 562-572, 2017.
2. Fan E, Brodie D and Slutsky AS: Acute respiratory distress syndrome: Advances in diagnosis and treatment. JAMA 319: 698-710, 2018.
3. Lau AN, Goodwin M, Kim CF and Weiss DJ: Stem cells and regenerative medicine in lung biology and diseases. Mol Ther 20: 1116-1130, 2012.
4. Weiss DJ: Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012. Ann Am Thorac Soc 10: S45-S97, 2013.
5. Lee JW, Gupta N, Serikov V and Matthay MA: Potential application of mesenchymal stem cells in acute lung injury. Expert Opin Biol Ther 9: 1259-1270, 2009.
6. Xu F, Hu Y, Zhou J and Wang X: Mesenchymal stem cells in acute lung injury: Are they ready for translational medicine?. J Cell Mol Med 17: 927-935, 2013.
7. Bustos ML, Huleihel L, Kapetanaki MG, Lino-C ardenas CL, Mroz L, Ellis BM, McVerry BJ, Richards TJ, Kaminski N, Cerdenes N, et al: Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response. Am J Respir Crit Care Med 189: 787-798, 2014.
8. Laffey JG and Matthay MA: Fifty years of research in ARDS. Cell-based therapy for acute respiratory distress syndrome. Biology and potential therapeutic value. Am J Respir Crit Care Med 196: 266-273, 2017.
9. Yang SR, Park JR and Kang KS: Reactive oxygen species in mesenchymal stem cell aging: Implication to lung diseases. Oxid Med Cell Longev 2015: 486263, 2015.
10. Espinoza F, Aliaga F and Crawford PL: Overview and perspectives of mesenchymal stem cell therapy in intensive care medicine. Rev Med Chil 144: 222-231, 2016 (In Spanish).
11. Li L, Dong L, Hui J, Gao F, Wang Q, Yang L, Zhang J and Yan J: Under-expression of LATS1 promotes the differentiation, proliferation and migration of mesenchymal stem cells by inhibition the Hippo signaling pathway in vitro. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 29: 731-737, 2017 (In Chinese).
12. National Research Council (US) Institute for Laboratory Animal Research: Guide for the Care and Use of Laboratory Animals. National Academies Press, Washington, DC, 1996.
13. Smith KM, Mrozek JD, Simonton SC, Bing DR, Meyers PA, Connett JE and Mammel MC: Prolonged partial liquid ventilation using conventional and high-frequency ventilatory techniques: Gas exchange and lung pathology in an animal model of respiratory distress syndrome. Crit Care Med 25: 1888-1897, 1997.
14. Ashcroft T, Simpson JM and Timbrell V: Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41: 467-470, 1988.
15. He H, Liu L, Chen Q, Liu A, Cai S, Yang Y, Lu X and Qiu H: Mesenchymal stem cells overexpressing angiotensin-converting enzyme 2 rescue lipopolysaccharide-induced lung injury. Cell Transplant 24: 1699-1715, 2015.
16. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-D elta Delta C(T)) method. Methods 25: 402-408, 2001.
17. Dong L, He HL, Lu XM, Yang Y and Qiu HB: Modulation of FLT3 signaling targets conventional dendritic cells to attenuate acute lung injury. APMIS 120: 808-818, 2012.
18. Sun Y, Liu JG, Zheng YC, Xiao C L, Wan B, Guo L, Wang XG and Bo W: Research on rat's pulmonary acute injury induced by lunar soil simulant. J Chin Med Assoc 81: 133-140, 2018.
19. Tam A, Wadsworth S, Dorscheid D, Man SF and Sin DD : The airway epithelium: More than just a structural barrier. Ther Adv Respir Dis 5: 255-273, 2011.
20. Standiford TJ and Ward PA: Therapeutic targeting of acute lung injury and acute respiratory distress syndrome. Transl Res 167: 183-191, 2016.
21. Moodley Y, Sturm M, Shaw K, Shimbori C, Tan DB, Kolb M and Graham R: Human mesenchymal stem cells attenuate early damage in a ventilated pig model of acute lung injury. Stem Cell Res 17: 25-31, 2016.
22. McIntyre LA, Moher D, Fergusson DA, Sullivan KJ, Mei SH, Lalu M, Marshall J, Mcleod M, Griffin G, Grimshaw J, et al: Efficacy of mesenchymal stromal cell therapy for acute lung injury in preclinical animal models: A systematic review. PLoS One 11: E0147170, 2016.
23. Hayes M, Curley G, Ansari B and Laffey JG: Clinical review: Stem cell therapies for acute lung injury/acute respiratory distress syndrome-hope or hype?. Crit Care 16: 205, 2012.
24. Sardo FL, Strano S and Blandino G: The Hippo kinase pathway: A master regulator of proliferation, development and differentiation. Atlas Genet Cytogenet Oncol Haematol 19: 65-77, 2015.
25. Johnson R and Halder G: The two faces of Hippo: Targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov 13: 63-79, 2014.
26. Zhang Q, Meng F, Chen S, Plouffe SW, Wu S, Liu S, Li X, Zhou R, Wang J, Zhao B, et al: Hippo signalling governs cytosolic nucleic acid sensing through YAP/TAZ-mediated TBK1 blockade. Nat Cell Biol 19: 362-374, 2017.
27. Zhao B, Tumaneng K and Guan KL: The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 13: 877-883, 2011.
28. Xu J, Woods CR, Mora AL, Joodi R, Brigham KL, Iyer S and Rojas M: Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol 293: L131-L141, 2007.
29. De Becker A, Van Hummelen P, Bakkus M, Vande Broek I, De Wever J, De Waele M and Van Riet I: Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica 92: 440-449, 2007.
30. Schioppa T, Uranchimeg B, Saccani A, Biswas SK, Doni A, Rapisarda A, Bernasconi S, Saccani S, Nebuloni M, Vago L, et al: Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 198: 1391-1402, 2003.
31. An Y, Kang Q, Zhao Y, Hu X and Li N: Lats2 modulates adipocyte proliferation and differentiation via hippo signalling. PLoS One 8: E72042, 2013.
32. Tang Y, Feinberg T, Keller ET, Li XY and Weiss SJ: Snail/Slug binding interactions with YAP/TAZ control skeletal stem cell self-renewal and differentiation. Nat Cell Biol 18: 917-929, 2016.
33. Chen Z, Luo Q, Lin C, Kuang D and Song G: Simulated microgravity inhibits osteogenic differentiation of mesenchymal stem cells via depolymerizing F-actin to impede TAZ nuclear translocation. Sci Rep 6: 30322, 2016.
34. He Q, Huang HY, Zhang YY, Li X, Qian SW and Tang QQ Tang: TAZ is downregulated by dexamethasone during the differentiation of 3T3-L1 preadipocytes. Biochem Biophys Res Commun 419: 573-577, 2012.
35. Deel MD, Li JJ, Crose LE and Linardic CM: A Review: Molecular aberrations within Hippo signaling in bone and soft-tissue sarcomas. Front Oncol 5: 190, 2015.
36. Lin X, Barravecchia M, Kothari P, Young JL and Dean DA: β1-Na(+), K(+)-ATPase gene therapy upregulates tight junctions to rescue lipopolysaccharide-induced acute lung injury. Gene Ther 23: 489-499, 2016.
37. Pati S, Gerber MH, Menge TD, Wataha KA, Zhao Y, Baumgartner JA, Zhao J, Letourneau PA, Huby MP, Baer LA, et al: Bone marrow derived mesenchymal stem cells inhibit inflammation and preserve vascular endothelial integrity in the lungs after hemorrhagic shock. PLoS One 6: E25171, 2011.
38. Voiriot G, Razazi K, Amsellem V, Tran Van Nhieu J, Abid S, Adnot S, Mekontso Dessap A and Maitre B: Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury. Respir Res 18: 64, 2017.
39. Zhu H, Xiong Y, Xia Y, Zhang R, Tian D, Wang T, Dai J, Wang L, Yao H, Jiang H, et al: Therapeutic effects of human umbilical cord-derived mesenchymal stem cells in acute lung injury mice. Sci Rep 7: 39889, 2017.
40. Nicoletti F, Mancuso G, Cusumano V, Di Marco R, Zaccone P, Bendtzen K and Teti G: Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13. Eur J Immunol 27: 1580-1583, 1997.
41. Qi D, Wang D, Zhang C, Tang X, He J, Zhao Y, Deng W and Deng X: Vaspin protects against LPSinduced ARDS by inhibiting inflammation, apoptosis and reactive oxygen species generation in pulmonary endothelial cells via the Akt/GSK3β pathway. Int J Mol Med 40: 1803-1817, 2017.
42. Kao KC, Hu HC, Chang CH, Hung CY, Chiu LC, Li SH, Lin SW, Chuang LP, Wang CW, Li LF, et al: Diffuse alveolar damage associated mortality in selected acute respiratory distress syndrome patients with open lung biopsy. Crit Care 19: 228, 2015.
43. Blondonnet R, Constantin JM, Sapin V and Jabaudon M: A pathophysiologic approach to biomarkers in acute respiratory distress syndrome. Dis Markers 2016: 3501373, 2016.
44. Wilcox ME and Herridge MS: Lung function and quality of life in survivors of the acute respiratory distress syndrome (ARDS). Presse Med 40: E595-603, 2011.
45. Huang K, Wu XM, Wang XY, Kang XW, Xiao JL, Li ZG and Lu P: The effect of marrow mesenchymal stem cell transplantation on pulmonary fibrosis in rats. Zhonghua Jie He He Hu Xi Za Zhi 35: 659-664, 2012 (In Chinese).
46. Fagone P, Mangano K, Mammana S, Pesce A, Pesce A, Caltabiano R, Giorlandino A, Portale TR, Cavalli E, Lombardo GA, et al: Identification of novel targets for the diagnosis and treatment of liver fibrosis. Int J Mol Med 36: 747-752, 2015.
47. Devaney J, Horie S, Masterson C, Elliman S, Barry F, O'Brien T, Curley GF, O'Toole D and Laffey JG: Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat. Thorax 70: 625-635, 2015.
48. Shen Q, Chen B, Xiao Z, Zhao L, Xu X, Wan X, Jin M, Dai J and Dai H: Paracrine factors from mesenchymal stem cells attenuate epithelial injury and lung fibrosis. Mol Med Rep 11: 2831-2837, 2015.
49. Fagone P, Mangano K, Pesce A, Portale TR, Puleo S and Nicoletti F: Emerging therapeutic targets for the treatment of hepatic fibrosis. Drug Discov Today 21: 369-375, 2016.
50. Shaver CM and Bastarache JA: Clinical and biological heterogeneity in acute respiratory distress syndrome: Direct versus indirect lung injury. Clin Chest Med 35: 639-653, 2014.
51. Liu L, Chen L, Jiang C, Guo J, Xie Y, Kang L and Cheng Z: Berberine inhibits the LPS-induced proliferation and inflammatory response of stromal cells of adenomyosis tissues mediated by the LPS/TLR4 signaling pathway. Exp Ther Med 14: 6125-6130, 2017.